Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Graft Rejection | 102 | 2023 | 1065 | 14.740 |
Why?
|
Transplantation Tolerance | 36 | 2023 | 130 | 11.950 |
Why?
|
B-Lymphocytes | 40 | 2022 | 724 | 9.180 |
Why?
|
Isoantibodies | 32 | 2023 | 114 | 8.820 |
Why?
|
Organ Transplantation | 25 | 2023 | 265 | 8.040 |
Why?
|
Heart Transplantation | 59 | 2023 | 705 | 6.680 |
Why?
|
Graft Survival | 49 | 2022 | 884 | 5.360 |
Why?
|
Kidney Transplantation | 24 | 2023 | 849 | 4.630 |
Why?
|
Immune Tolerance | 25 | 2023 | 337 | 4.410 |
Why?
|
T-Lymphocytes | 35 | 2022 | 1195 | 3.740 |
Why?
|
Immunosuppressive Agents | 53 | 2017 | 977 | 3.690 |
Why?
|
Immunologic Memory | 13 | 2022 | 152 | 3.440 |
Why?
|
Isoxazoles | 41 | 2006 | 77 | 3.410 |
Why?
|
Transplantation, Heterologous | 38 | 2007 | 363 | 3.320 |
Why?
|
Mice | 122 | 2023 | 11352 | 2.810 |
Why?
|
Transplantation, Homologous | 41 | 2023 | 996 | 2.540 |
Why?
|
Allografts | 15 | 2023 | 172 | 2.480 |
Why?
|
Animals | 172 | 2023 | 26581 | 2.440 |
Why?
|
Lymphocyte Activation | 24 | 2017 | 728 | 2.370 |
Why?
|
Isoantigens | 11 | 2023 | 66 | 2.250 |
Why?
|
CD4-Positive T-Lymphocytes | 14 | 2023 | 425 | 2.160 |
Why?
|
CD40 Ligand | 11 | 2013 | 69 | 2.070 |
Why?
|
Mice, Inbred BALB C | 39 | 2022 | 1047 | 2.000 |
Why?
|
HLA Antigens | 9 | 2023 | 232 | 1.980 |
Why?
|
Germinal Center | 4 | 2020 | 55 | 1.940 |
Why?
|
Immunity, Humoral | 4 | 2018 | 67 | 1.850 |
Why?
|
Islets of Langerhans Transplantation | 16 | 2012 | 225 | 1.840 |
Why?
|
Mice, Inbred C57BL | 49 | 2022 | 3092 | 1.840 |
Why?
|
Skin Transplantation | 12 | 2022 | 172 | 1.820 |
Why?
|
Tissue Donors | 13 | 2023 | 463 | 1.660 |
Why?
|
Transplantation Immunology | 8 | 2019 | 84 | 1.640 |
Why?
|
CTLA-4 Antigen | 8 | 2016 | 135 | 1.610 |
Why?
|
Immunoglobulin G | 12 | 2023 | 456 | 1.600 |
Why?
|
Diabetes Mellitus, Experimental | 12 | 2013 | 190 | 1.580 |
Why?
|
Disaccharides | 11 | 2008 | 23 | 1.460 |
Why?
|
Antibodies, Monoclonal | 20 | 2023 | 1376 | 1.440 |
Why?
|
Listeriosis | 6 | 2019 | 84 | 1.430 |
Why?
|
Toll-Like Receptors | 6 | 2009 | 92 | 1.400 |
Why?
|
Listeria monocytogenes | 5 | 2019 | 89 | 1.390 |
Why?
|
Galactosyltransferases | 11 | 2014 | 40 | 1.350 |
Why?
|
Abatacept | 9 | 2020 | 83 | 1.340 |
Why?
|
Nanofibers | 7 | 2020 | 31 | 1.330 |
Why?
|
Major Histocompatibility Complex | 5 | 2023 | 81 | 1.330 |
Why?
|
CD8-Positive T-Lymphocytes | 9 | 2023 | 559 | 1.280 |
Why?
|
T-Lymphocyte Subsets | 9 | 2019 | 272 | 1.270 |
Why?
|
Killer Cells, Natural | 13 | 2008 | 267 | 1.260 |
Why?
|
Rats, Inbred Lew | 38 | 2008 | 186 | 1.250 |
Why?
|
Interferon-gamma | 15 | 2016 | 444 | 1.210 |
Why?
|
B-Lymphocytes, Regulatory | 3 | 2019 | 8 | 1.180 |
Why?
|
Bacterial Infections | 4 | 2014 | 182 | 1.140 |
Why?
|
Humans | 110 | 2023 | 86601 | 1.130 |
Why?
|
T-Lymphocytes, Helper-Inducer | 5 | 2023 | 132 | 1.110 |
Why?
|
Antibodies | 11 | 2022 | 350 | 1.100 |
Why?
|
Rats | 54 | 2023 | 3990 | 1.080 |
Why?
|
Insulin-Secreting Cells | 4 | 2013 | 397 | 1.070 |
Why?
|
Antigen-Presenting Cells | 6 | 2020 | 139 | 1.060 |
Why?
|
Spleen | 12 | 2020 | 430 | 1.020 |
Why?
|
Immunoconjugates | 6 | 2016 | 106 | 0.990 |
Why?
|
B-Lymphocyte Subsets | 3 | 2018 | 40 | 0.980 |
Why?
|
Phenanthrenes | 1 | 2023 | 2 | 0.960 |
Why?
|
Diterpenes | 1 | 2023 | 20 | 0.950 |
Why?
|
Staphylococcus aureus | 9 | 2022 | 263 | 0.950 |
Why?
|
Histocompatibility Antigens Class II | 6 | 2023 | 158 | 0.950 |
Why?
|
Mice, Knockout | 29 | 2019 | 1924 | 0.940 |
Why?
|
Prodrugs | 1 | 2023 | 46 | 0.940 |
Why?
|
Staphylococcal Infections | 5 | 2022 | 255 | 0.920 |
Why?
|
Dendritic Cells | 3 | 2023 | 425 | 0.910 |
Why?
|
Sugars | 1 | 2022 | 3 | 0.900 |
Why?
|
Regeneration | 5 | 2014 | 143 | 0.880 |
Why?
|
Disease Models, Animal | 12 | 2020 | 2232 | 0.870 |
Why?
|
Mice, Transgenic | 15 | 2021 | 1540 | 0.850 |
Why?
|
Antibody Formation | 14 | 2022 | 171 | 0.840 |
Why?
|
Adaptive Immunity | 6 | 2020 | 164 | 0.840 |
Why?
|
Antigens | 5 | 2022 | 228 | 0.830 |
Why?
|
Diabetes Mellitus, Type 1 | 7 | 2012 | 567 | 0.830 |
Why?
|
Cyclosporine | 20 | 2000 | 234 | 0.820 |
Why?
|
Inflammation | 8 | 2022 | 920 | 0.800 |
Why?
|
Signal Transduction | 13 | 2023 | 3241 | 0.800 |
Why?
|
Interleukin-10 | 3 | 2017 | 149 | 0.790 |
Why?
|
Fetal Tissue Transplantation | 1 | 2021 | 11 | 0.790 |
Why?
|
Female | 46 | 2023 | 44507 | 0.760 |
Why?
|
Killer Cells, Lymphokine-Activated | 10 | 1996 | 27 | 0.750 |
Why?
|
Autoimmunity | 3 | 2019 | 160 | 0.740 |
Why?
|
Pancreas Transplantation | 6 | 2008 | 103 | 0.740 |
Why?
|
Fetus | 2 | 2021 | 226 | 0.730 |
Why?
|
Congresses as Topic | 1 | 2020 | 116 | 0.700 |
Why?
|
T-Lymphocytes, Cytotoxic | 4 | 2016 | 315 | 0.700 |
Why?
|
Transplants | 3 | 2022 | 40 | 0.700 |
Why?
|
Desensitization, Immunologic | 1 | 2019 | 36 | 0.700 |
Why?
|
Peptides | 9 | 2023 | 639 | 0.690 |
Why?
|
Kidney | 9 | 2023 | 1241 | 0.680 |
Why?
|
Plasma Cells | 3 | 2017 | 80 | 0.680 |
Why?
|
Complement Activation | 3 | 2008 | 81 | 0.680 |
Why?
|
Mice, Inbred C3H | 12 | 2011 | 370 | 0.670 |
Why?
|
Th1 Cells | 2 | 2014 | 164 | 0.660 |
Why?
|
Th2 Cells | 2 | 2014 | 146 | 0.660 |
Why?
|
Adjuvants, Immunologic | 6 | 2020 | 167 | 0.660 |
Why?
|
Histocompatibility Antigens Class I | 5 | 2023 | 203 | 0.660 |
Why?
|
Apoptosis | 5 | 2023 | 1683 | 0.630 |
Why?
|
Immunologic Techniques | 1 | 2017 | 27 | 0.630 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 645 | 0.630 |
Why?
|
Receptors, Antigen, B-Cell | 4 | 2023 | 113 | 0.630 |
Why?
|
Receptors, IgG | 7 | 2008 | 52 | 0.630 |
Why?
|
T-Lymphocytes, Regulatory | 7 | 2022 | 295 | 0.630 |
Why?
|
Cytokines | 9 | 2023 | 776 | 0.610 |
Why?
|
Staphylococcal Skin Infections | 4 | 2022 | 25 | 0.610 |
Why?
|
Interleukin-2 | 13 | 2022 | 249 | 0.600 |
Why?
|
Influenza Vaccines | 2 | 2018 | 142 | 0.600 |
Why?
|
Tumor Necrosis Factor-alpha | 15 | 2017 | 683 | 0.600 |
Why?
|
Cytotoxicity, Immunologic | 9 | 1995 | 213 | 0.580 |
Why?
|
Antineoplastic Agents | 3 | 2023 | 2357 | 0.570 |
Why?
|
B7-H1 Antigen | 4 | 2023 | 250 | 0.570 |
Why?
|
Antigens, Differentiation | 7 | 2004 | 141 | 0.560 |
Why?
|
Transplantation, Heterotopic | 11 | 2010 | 45 | 0.560 |
Why?
|
Clonal Deletion | 3 | 2020 | 23 | 0.550 |
Why?
|
Acute Kidney Injury | 1 | 2019 | 295 | 0.530 |
Why?
|
Monitoring, Immunologic | 2 | 2015 | 17 | 0.530 |
Why?
|
Antigens, CD | 13 | 2018 | 458 | 0.520 |
Why?
|
Interleukin-6 | 3 | 2011 | 256 | 0.520 |
Why?
|
Cell Lineage | 1 | 2016 | 273 | 0.520 |
Why?
|
Allergy and Immunology | 1 | 2015 | 12 | 0.520 |
Why?
|
Cell Proliferation | 6 | 2019 | 1578 | 0.520 |
Why?
|
Biomedical Research | 2 | 2020 | 375 | 0.520 |
Why?
|
Precision Medicine | 1 | 2019 | 395 | 0.520 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2022 | 878 | 0.520 |
Why?
|
Luciferases | 4 | 2013 | 118 | 0.510 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2018 | 89 | 0.510 |
Why?
|
Laboratories | 1 | 2015 | 43 | 0.510 |
Why?
|
Pregnancy | 4 | 2022 | 2893 | 0.500 |
Why?
|
International Cooperation | 1 | 2015 | 127 | 0.500 |
Why?
|
CD3 Complex | 8 | 2012 | 135 | 0.490 |
Why?
|
Islets of Langerhans | 7 | 2010 | 544 | 0.480 |
Why?
|
Antibodies, Bacterial | 4 | 2022 | 95 | 0.480 |
Why?
|
Kidney Failure, Chronic | 2 | 2021 | 509 | 0.480 |
Why?
|
Models, Animal | 5 | 2017 | 263 | 0.470 |
Why?
|
Male | 45 | 2023 | 40956 | 0.470 |
Why?
|
Membrane Glycoproteins | 9 | 1998 | 428 | 0.460 |
Why?
|
Societies, Medical | 4 | 2022 | 572 | 0.460 |
Why?
|
Communicable Diseases | 1 | 2014 | 63 | 0.450 |
Why?
|
Uracil | 1 | 2013 | 72 | 0.450 |
Why?
|
Antibodies, Heterophile | 5 | 2004 | 20 | 0.450 |
Why?
|
Antiviral Agents | 5 | 2006 | 510 | 0.450 |
Why?
|
Protein-Tyrosine Kinases | 6 | 1998 | 302 | 0.450 |
Why?
|
Thiazolidinediones | 1 | 2013 | 82 | 0.450 |
Why?
|
Up-Regulation | 4 | 2010 | 712 | 0.430 |
Why?
|
Bone Transplantation | 2 | 2003 | 64 | 0.430 |
Why?
|
Gender Identity | 2 | 2023 | 52 | 0.430 |
Why?
|
Epitopes | 9 | 2017 | 255 | 0.420 |
Why?
|
Blood Glucose | 6 | 2016 | 873 | 0.410 |
Why?
|
Receptors, Immunologic | 6 | 1996 | 135 | 0.410 |
Why?
|
Cytomegalovirus | 3 | 2006 | 76 | 0.410 |
Why?
|
Piperidines | 1 | 2013 | 181 | 0.410 |
Why?
|
Renal Insufficiency | 1 | 2012 | 114 | 0.410 |
Why?
|
CD4 Antigens | 6 | 2007 | 83 | 0.400 |
Why?
|
Cytomegalovirus Infections | 4 | 2006 | 144 | 0.400 |
Why?
|
Hydroxybutyrates | 4 | 1999 | 27 | 0.400 |
Why?
|
Aniline Compounds | 4 | 1999 | 55 | 0.390 |
Why?
|
Vaccines, Subunit | 4 | 2020 | 55 | 0.390 |
Why?
|
Treatment Outcome | 8 | 2020 | 7988 | 0.370 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 378 | 0.370 |
Why?
|
Tacrolimus | 6 | 2013 | 373 | 0.370 |
Why?
|
Bacteria | 1 | 2014 | 447 | 0.360 |
Why?
|
Lymphocyte Depletion | 3 | 2010 | 97 | 0.360 |
Why?
|
Receptors, Antigen, T-Cell | 6 | 2017 | 372 | 0.350 |
Why?
|
Liver | 8 | 2008 | 1229 | 0.350 |
Why?
|
Phenotype | 9 | 2016 | 2377 | 0.350 |
Why?
|
Immunoglobulin M | 8 | 2014 | 154 | 0.350 |
Why?
|
Down-Regulation | 1 | 2010 | 504 | 0.340 |
Why?
|
Insulin | 2 | 2013 | 1160 | 0.330 |
Why?
|
Uridine | 9 | 2006 | 56 | 0.330 |
Why?
|
Graft vs Host Disease | 3 | 2009 | 365 | 0.330 |
Why?
|
Biomarkers | 4 | 2023 | 1718 | 0.320 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 6 | 1994 | 95 | 0.320 |
Why?
|
Time Factors | 15 | 2016 | 5209 | 0.320 |
Why?
|
Lymphoproliferative Disorders | 3 | 1997 | 107 | 0.320 |
Why?
|
alpha-Galactosidase | 1 | 2007 | 5 | 0.320 |
Why?
|
Histocompatibility | 4 | 2023 | 71 | 0.320 |
Why?
|
Lung | 3 | 2023 | 1170 | 0.320 |
Why?
|
CD59 Antigens | 1 | 2007 | 17 | 0.320 |
Why?
|
Cricetinae | 13 | 2000 | 560 | 0.310 |
Why?
|
Biphenyl Compounds | 2 | 1998 | 68 | 0.310 |
Why?
|
Antigens, Surface | 1 | 2007 | 101 | 0.310 |
Why?
|
Ischemic Preconditioning | 2 | 2006 | 37 | 0.310 |
Why?
|
Mesocricetus | 12 | 2000 | 107 | 0.300 |
Why?
|
Autoimmune Diseases | 3 | 1998 | 241 | 0.300 |
Why?
|
Receptors, Cell Surface | 2 | 2007 | 286 | 0.300 |
Why?
|
Leukocyte Common Antigens | 3 | 1995 | 46 | 0.290 |
Why?
|
Bone Marrow Transplantation | 3 | 2023 | 286 | 0.290 |
Why?
|
Stem Cell Transplantation | 1 | 2008 | 183 | 0.290 |
Why?
|
Lymph Nodes | 4 | 2023 | 530 | 0.290 |
Why?
|
Freund's Adjuvant | 1 | 2006 | 26 | 0.280 |
Why?
|
Cell Transplantation | 1 | 2006 | 47 | 0.280 |
Why?
|
NF-kappa B | 4 | 2023 | 444 | 0.280 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 469 | 0.280 |
Why?
|
Consensus | 2 | 2020 | 335 | 0.280 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 2270 | 0.270 |
Why?
|
Reperfusion Injury | 5 | 2014 | 131 | 0.270 |
Why?
|
Cell Differentiation | 7 | 2018 | 1458 | 0.260 |
Why?
|
Endothelium, Vascular | 3 | 2003 | 435 | 0.260 |
Why?
|
Mice, Inbred Strains | 6 | 2015 | 307 | 0.260 |
Why?
|
Cell Adhesion Molecules | 3 | 1994 | 163 | 0.260 |
Why?
|
Interferon Regulatory Factors | 2 | 2017 | 67 | 0.260 |
Why?
|
Exotoxins | 2 | 2022 | 20 | 0.260 |
Why?
|
Cells, Cultured | 12 | 2007 | 2818 | 0.260 |
Why?
|
Histocompatibility Testing | 3 | 2023 | 154 | 0.260 |
Why?
|
Acute Disease | 6 | 2009 | 826 | 0.260 |
Why?
|
Genes, Reporter | 4 | 2019 | 268 | 0.250 |
Why?
|
Skin | 2 | 2019 | 554 | 0.250 |
Why?
|
Flow Cytometry | 6 | 2018 | 679 | 0.250 |
Why?
|
Immunity, Innate | 3 | 2020 | 409 | 0.240 |
Why?
|
Epoxy Compounds | 1 | 2023 | 6 | 0.240 |
Why?
|
Antilymphocyte Serum | 2 | 2020 | 71 | 0.240 |
Why?
|
Cross-Priming | 1 | 2023 | 48 | 0.230 |
Why?
|
Sex Factors | 3 | 2023 | 1054 | 0.230 |
Why?
|
Immunization | 3 | 2020 | 158 | 0.230 |
Why?
|
Transplantation Chimera | 3 | 2023 | 80 | 0.230 |
Why?
|
Organ Specificity | 2 | 2022 | 258 | 0.220 |
Why?
|
Cell Line | 12 | 2017 | 2468 | 0.220 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2023 | 27 | 0.220 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2022 | 6 | 0.220 |
Why?
|
Immunoglobulin Class Switching | 2 | 2016 | 37 | 0.220 |
Why?
|
Antibody Specificity | 2 | 2020 | 129 | 0.220 |
Why?
|
Myeloid Differentiation Factor 88 | 4 | 2012 | 47 | 0.210 |
Why?
|
Microbiota | 3 | 2019 | 381 | 0.210 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2020 | 100 | 0.210 |
Why?
|
Leukocidins | 1 | 2022 | 3 | 0.210 |
Why?
|
Swine | 9 | 2004 | 555 | 0.210 |
Why?
|
Streptozocin | 2 | 2013 | 54 | 0.210 |
Why?
|
CD8 Antigens | 3 | 2000 | 82 | 0.210 |
Why?
|
Europe | 2 | 2020 | 309 | 0.210 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 4 | 1995 | 10 | 0.200 |
Why?
|
Publications | 1 | 2021 | 26 | 0.200 |
Why?
|
Honey | 1 | 2000 | 3 | 0.200 |
Why?
|
Botulism | 1 | 2000 | 6 | 0.200 |
Why?
|
Interleukin-17 | 2 | 2014 | 101 | 0.200 |
Why?
|
DNA-Binding Proteins | 5 | 2013 | 1208 | 0.200 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 73 | 0.190 |
Why?
|
Tyrosine | 5 | 1999 | 133 | 0.190 |
Why?
|
Gene Expression Regulation | 7 | 2021 | 1920 | 0.190 |
Why?
|
Liver Transplantation | 9 | 2002 | 1267 | 0.190 |
Why?
|
Transplantation | 1 | 2020 | 39 | 0.190 |
Why?
|
Trans-Activators | 3 | 2013 | 429 | 0.190 |
Why?
|
H-2 Antigens | 3 | 2020 | 58 | 0.190 |
Why?
|
Leadership | 1 | 2022 | 134 | 0.190 |
Why?
|
Transcription Factors | 4 | 2022 | 1565 | 0.190 |
Why?
|
Nitriles | 6 | 2005 | 149 | 0.190 |
Why?
|
Immunodominant Epitopes | 1 | 2020 | 19 | 0.190 |
Why?
|
Antigens, T-Independent | 1 | 2000 | 4 | 0.190 |
Why?
|
Growth Inhibitors | 3 | 2004 | 41 | 0.190 |
Why?
|
Green Fluorescent Proteins | 4 | 2014 | 305 | 0.180 |
Why?
|
Tumor Cells, Cultured | 9 | 1999 | 1041 | 0.180 |
Why?
|
Risk Factors | 4 | 2023 | 5416 | 0.180 |
Why?
|
North America | 1 | 2020 | 180 | 0.180 |
Why?
|
Bacterial Proteins | 2 | 2016 | 864 | 0.180 |
Why?
|
Cell Division | 7 | 1999 | 696 | 0.180 |
Why?
|
Macrophages | 4 | 1990 | 554 | 0.180 |
Why?
|
Cell Line, Tumor | 2 | 2023 | 2426 | 0.180 |
Why?
|
Immunohistochemistry | 5 | 2014 | 1753 | 0.180 |
Why?
|
Phosphorylation | 7 | 1999 | 1106 | 0.170 |
Why?
|
src-Family Kinases | 2 | 1997 | 74 | 0.170 |
Why?
|
Isoenzymes | 3 | 2013 | 271 | 0.170 |
Why?
|
Promoter Regions, Genetic | 3 | 2013 | 937 | 0.170 |
Why?
|
fas Receptor | 2 | 1999 | 75 | 0.170 |
Why?
|
Granzymes | 1 | 2019 | 93 | 0.170 |
Why?
|
Thymus Gland | 1 | 2020 | 195 | 0.170 |
Why?
|
Cytidine Deaminase | 2 | 2016 | 43 | 0.170 |
Why?
|
Crotonates | 4 | 1999 | 11 | 0.170 |
Why?
|
Glucose Tolerance Test | 3 | 2010 | 228 | 0.170 |
Why?
|
Toluidines | 4 | 1999 | 17 | 0.170 |
Why?
|
MAP Kinase Signaling System | 2 | 2018 | 192 | 0.170 |
Why?
|
Antigen Presentation | 1 | 2020 | 209 | 0.160 |
Why?
|
Cell Adhesion | 6 | 1995 | 420 | 0.160 |
Why?
|
Models, Immunological | 2 | 2017 | 80 | 0.160 |
Why?
|
Orthomyxoviridae Infections | 1 | 2018 | 46 | 0.160 |
Why?
|
Bacterial Vaccines | 2 | 2017 | 41 | 0.160 |
Why?
|
Proto-Oncogene Proteins | 3 | 2013 | 645 | 0.160 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 350 | 0.160 |
Why?
|
Mice, SCID | 2 | 2010 | 252 | 0.160 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 231 | 0.160 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 916 | 0.160 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 1997 | 9 | 0.150 |
Why?
|
Mice, Inbred NOD | 6 | 2008 | 187 | 0.150 |
Why?
|
Drug Resistance | 3 | 1993 | 256 | 0.150 |
Why?
|
Leukocytes, Mononuclear | 3 | 2020 | 196 | 0.150 |
Why?
|
Hybridomas | 3 | 2008 | 74 | 0.150 |
Why?
|
Oxidoreductases | 1 | 1997 | 112 | 0.150 |
Why?
|
Clonal Anergy | 1 | 2017 | 30 | 0.150 |
Why?
|
Neoplasm Proteins | 3 | 1995 | 532 | 0.150 |
Why?
|
Mice, Inbred DBA | 3 | 2002 | 148 | 0.150 |
Why?
|
Autoantibodies | 3 | 2021 | 267 | 0.150 |
Why?
|
Adoptive Transfer | 6 | 2016 | 168 | 0.150 |
Why?
|
Leukemia, Experimental | 1 | 1996 | 15 | 0.150 |
Why?
|
Central Tolerance | 1 | 2016 | 8 | 0.150 |
Why?
|
Immune Sera | 5 | 2003 | 52 | 0.150 |
Why?
|
Cell Tracking | 1 | 2016 | 14 | 0.150 |
Why?
|
Neutralization Tests | 2 | 2014 | 77 | 0.140 |
Why?
|
Transplant Recipients | 1 | 2018 | 122 | 0.140 |
Why?
|
Integrases | 1 | 2016 | 59 | 0.140 |
Why?
|
RNA, Untranslated | 1 | 2016 | 63 | 0.140 |
Why?
|
Vaccines | 2 | 2014 | 80 | 0.140 |
Why?
|
Cell Movement | 1 | 2020 | 758 | 0.140 |
Why?
|
Polysaccharides | 2 | 2014 | 89 | 0.140 |
Why?
|
Kinetics | 5 | 2016 | 1513 | 0.140 |
Why?
|
Lymphotoxin-alpha | 2 | 1993 | 44 | 0.140 |
Why?
|
Luminescent Proteins | 1 | 2016 | 144 | 0.140 |
Why?
|
Programmed Cell Death 1 Ligand 2 Protein | 1 | 2015 | 10 | 0.140 |
Why?
|
5'-Nucleotidase | 1 | 2015 | 13 | 0.140 |
Why?
|
Biocompatible Materials | 2 | 2014 | 193 | 0.140 |
Why?
|
Peptide Fragments | 3 | 2012 | 460 | 0.130 |
Why?
|
Drug Synergism | 3 | 2013 | 303 | 0.130 |
Why?
|
Hemolysin Proteins | 2 | 2022 | 34 | 0.130 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
Diet, High-Fat | 1 | 2016 | 114 | 0.130 |
Why?
|
Anti-Bacterial Agents | 3 | 2016 | 746 | 0.130 |
Why?
|
Lymphocytes | 3 | 2008 | 464 | 0.130 |
Why?
|
Sirolimus | 2 | 2013 | 169 | 0.130 |
Why?
|
Plasmodium | 1 | 2014 | 10 | 0.130 |
Why?
|
Pyrimidine Nucleotides | 3 | 1999 | 7 | 0.130 |
Why?
|
Organizational Objectives | 1 | 2015 | 27 | 0.130 |
Why?
|
Malaria, Falciparum | 1 | 2014 | 12 | 0.130 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 296 | 0.130 |
Why?
|
Prognosis | 2 | 2014 | 3674 | 0.130 |
Why?
|
Bacterial Toxins | 2 | 2022 | 111 | 0.130 |
Why?
|
Transfection | 4 | 1998 | 896 | 0.120 |
Why?
|
Gene Expression | 3 | 2013 | 1284 | 0.120 |
Why?
|
Protein Kinases | 1 | 2015 | 209 | 0.120 |
Why?
|
Macromolecular Substances | 1 | 2014 | 177 | 0.120 |
Why?
|
Rabbits | 2 | 2013 | 636 | 0.120 |
Why?
|
Antigen-Antibody Complex | 1 | 2014 | 87 | 0.120 |
Why?
|
Toll-Like Receptor 9 | 2 | 2014 | 20 | 0.120 |
Why?
|
Cell Cycle Proteins | 1 | 1996 | 388 | 0.120 |
Why?
|
CD2 Antigens | 4 | 1994 | 22 | 0.120 |
Why?
|
Research Report | 1 | 2014 | 44 | 0.120 |
Why?
|
Cooperative Behavior | 1 | 2015 | 174 | 0.120 |
Why?
|
Antigens, CD20 | 2 | 2012 | 36 | 0.120 |
Why?
|
Nanostructures | 1 | 2014 | 77 | 0.120 |
Why?
|
Luminescent Measurements | 1 | 2013 | 57 | 0.120 |
Why?
|
Protein Kinase C | 2 | 2013 | 270 | 0.110 |
Why?
|
Intestine, Small | 4 | 1998 | 303 | 0.110 |
Why?
|
Dermatitis | 1 | 2013 | 32 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 6 | 1999 | 1961 | 0.110 |
Why?
|
Immunity, Cellular | 5 | 2008 | 177 | 0.110 |
Why?
|
Vaccines, Synthetic | 1 | 2013 | 55 | 0.110 |
Why?
|
Injections, Intravenous | 2 | 2003 | 244 | 0.110 |
Why?
|
Syndecan-1 | 1 | 2012 | 13 | 0.110 |
Why?
|
Immunoglobulins | 1 | 2013 | 148 | 0.110 |
Why?
|
Drug Therapy, Combination | 6 | 1998 | 894 | 0.110 |
Why?
|
Antibodies, Viral | 1 | 2014 | 293 | 0.110 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 1673 | 0.110 |
Why?
|
Complement C4b | 1 | 2012 | 35 | 0.110 |
Why?
|
Malaria | 1 | 2012 | 23 | 0.110 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 3 | 1997 | 33 | 0.110 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 1034 | 0.110 |
Why?
|
Binding, Competitive | 3 | 1999 | 145 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2022 | 376 | 0.100 |
Why?
|
Tetradecanoylphorbol Acetate | 3 | 2018 | 137 | 0.100 |
Why?
|
Group Processes | 2 | 2023 | 31 | 0.100 |
Why?
|
Heat-Shock Proteins | 2 | 2014 | 179 | 0.100 |
Why?
|
Escherichia coli | 1 | 2014 | 597 | 0.100 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1992 | 100 | 0.100 |
Why?
|
Genotype | 1 | 2016 | 1850 | 0.100 |
Why?
|
Viral Proteins | 2 | 2006 | 300 | 0.100 |
Why?
|
Adult | 8 | 2016 | 25640 | 0.100 |
Why?
|
Antigens, Neoplasm | 2 | 2005 | 325 | 0.100 |
Why?
|
Methylprednisolone | 1 | 2011 | 66 | 0.100 |
Why?
|
Prospective Studies | 3 | 2022 | 4210 | 0.100 |
Why?
|
Species Specificity | 4 | 2000 | 678 | 0.100 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2014 | 223 | 0.100 |
Why?
|
Leukocyte Transfusion | 1 | 2010 | 15 | 0.100 |
Why?
|
Intercellular Adhesion Molecule-1 | 4 | 1995 | 71 | 0.100 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 1990 | 12 | 0.100 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 1992 | 123 | 0.100 |
Why?
|
Glomerular Filtration Rate | 1 | 2012 | 384 | 0.100 |
Why?
|
Injections, Intraperitoneal | 2 | 2003 | 102 | 0.100 |
Why?
|
Bronchiolitis Obliterans | 1 | 2010 | 31 | 0.090 |
Why?
|
Th17 Cells | 1 | 2011 | 80 | 0.090 |
Why?
|
Combined Modality Therapy | 2 | 2006 | 1685 | 0.090 |
Why?
|
Pancreatic Diseases | 1 | 2010 | 52 | 0.090 |
Why?
|
Crosses, Genetic | 1 | 2010 | 171 | 0.090 |
Why?
|
CD28 Antigens | 2 | 2004 | 88 | 0.090 |
Why?
|
Cell Death | 3 | 2007 | 256 | 0.090 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 857 | 0.090 |
Why?
|
CD58 Antigens | 3 | 1994 | 5 | 0.090 |
Why?
|
Interferon-beta | 1 | 2010 | 125 | 0.090 |
Why?
|
Aging | 1 | 2014 | 691 | 0.090 |
Why?
|
Drug Resistance, Microbial | 2 | 1999 | 72 | 0.090 |
Why?
|
Pseudomonas aeruginosa | 1 | 2011 | 194 | 0.090 |
Why?
|
Obesity | 1 | 2016 | 963 | 0.090 |
Why?
|
Monocytes | 1 | 1990 | 214 | 0.090 |
Why?
|
Ischemia | 2 | 2014 | 243 | 0.090 |
Why?
|
Gene Knock-In Techniques | 1 | 2009 | 28 | 0.090 |
Why?
|
Middle Aged | 7 | 2014 | 25017 | 0.090 |
Why?
|
Heart | 2 | 2016 | 539 | 0.080 |
Why?
|
Microspheres | 1 | 1988 | 101 | 0.080 |
Why?
|
Lipopolysaccharides | 5 | 2017 | 286 | 0.080 |
Why?
|
Lung Transplantation | 1 | 2010 | 175 | 0.080 |
Why?
|
Tandem Repeat Sequences | 1 | 2008 | 26 | 0.080 |
Why?
|
Bystander Effect | 1 | 2008 | 12 | 0.080 |
Why?
|
Biopsy | 1 | 2012 | 1161 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 8 | 1999 | 1219 | 0.080 |
Why?
|
DNA, Viral | 2 | 1999 | 265 | 0.080 |
Why?
|
Interleukin-18 | 1 | 2008 | 26 | 0.080 |
Why?
|
Luminescence | 1 | 2008 | 16 | 0.080 |
Why?
|
Fibroblasts | 3 | 2003 | 729 | 0.080 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2008 | 72 | 0.080 |
Why?
|
Interleukin-1 | 1 | 2008 | 71 | 0.080 |
Why?
|
Ovalbumin | 2 | 2022 | 109 | 0.080 |
Why?
|
Receptors, Interleukin-2 | 3 | 2005 | 66 | 0.080 |
Why?
|
Cell- and Tissue-Based Therapy | 1 | 2008 | 49 | 0.080 |
Why?
|
Cross Infection | 1 | 2009 | 141 | 0.080 |
Why?
|
Reference Values | 2 | 2006 | 674 | 0.080 |
Why?
|
Protein Structure, Secondary | 3 | 2014 | 330 | 0.080 |
Why?
|
Complement System Proteins | 1 | 2008 | 81 | 0.080 |
Why?
|
Mice, Nude | 3 | 2013 | 790 | 0.080 |
Why?
|
Interferon Type I | 1 | 2008 | 175 | 0.080 |
Why?
|
In Vitro Techniques | 3 | 1995 | 989 | 0.080 |
Why?
|
Blotting, Northern | 2 | 1999 | 256 | 0.080 |
Why?
|
Ligands | 1 | 2008 | 433 | 0.070 |
Why?
|
Risk Assessment | 1 | 2014 | 2261 | 0.070 |
Why?
|
Transcription Factor AP-1 | 2 | 2013 | 65 | 0.070 |
Why?
|
Protein Binding | 3 | 2020 | 1456 | 0.070 |
Why?
|
Leukemia, Erythroblastic, Acute | 3 | 1992 | 29 | 0.070 |
Why?
|
Receptors, Antigen | 1 | 1986 | 11 | 0.070 |
Why?
|
Rats, Inbred ACI | 4 | 2001 | 25 | 0.070 |
Why?
|
Rats, Inbred BN | 5 | 2005 | 37 | 0.070 |
Why?
|
Blotting, Western | 3 | 2001 | 782 | 0.070 |
Why?
|
Type C Phospholipases | 2 | 1996 | 28 | 0.070 |
Why?
|
Salivary Glands | 1 | 2006 | 18 | 0.070 |
Why?
|
Organ Preservation | 2 | 2014 | 83 | 0.070 |
Why?
|
Embolism | 1 | 2006 | 31 | 0.070 |
Why?
|
Amino Acid Sequence | 4 | 2013 | 2062 | 0.070 |
Why?
|
Lectins, C-Type | 1 | 2006 | 85 | 0.070 |
Why?
|
Caspase 3 | 1 | 2006 | 159 | 0.070 |
Why?
|
Caspases | 1 | 2006 | 155 | 0.070 |
Why?
|
Carrageenan | 1 | 1985 | 9 | 0.070 |
Why?
|
Age Factors | 3 | 2014 | 1849 | 0.070 |
Why?
|
Portal Vein | 1 | 2006 | 120 | 0.070 |
Why?
|
Bone Marrow | 2 | 1998 | 435 | 0.070 |
Why?
|
Enzyme Inhibitors | 3 | 1999 | 639 | 0.060 |
Why?
|
Autoantigens | 2 | 2016 | 127 | 0.060 |
Why?
|
Fasting | 2 | 1995 | 161 | 0.060 |
Why?
|
Infant | 2 | 2022 | 3045 | 0.060 |
Why?
|
Tilapia | 1 | 2004 | 1 | 0.060 |
Why?
|
Hyperglycemia | 1 | 2006 | 176 | 0.060 |
Why?
|
Young Adult | 4 | 2022 | 5974 | 0.060 |
Why?
|
Interleukin-4 | 2 | 2002 | 127 | 0.060 |
Why?
|
Immunity | 2 | 2022 | 136 | 0.060 |
Why?
|
Molecular Sequence Data | 5 | 2012 | 3030 | 0.060 |
Why?
|
Sporozoites | 2 | 2014 | 2 | 0.060 |
Why?
|
Diabetes Mellitus | 2 | 2004 | 806 | 0.060 |
Why?
|
Antibodies, Protozoan | 2 | 2014 | 34 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2004 | 165 | 0.060 |
Why?
|
Stem Cells | 1 | 2006 | 351 | 0.060 |
Why?
|
Myocardium | 2 | 2004 | 529 | 0.060 |
Why?
|
Binding Sites, Antibody | 1 | 2003 | 49 | 0.060 |
Why?
|
Chimerism | 1 | 2023 | 37 | 0.060 |
Why?
|
Cloning, Organism | 1 | 2003 | 19 | 0.060 |
Why?
|
Antibody Affinity | 1 | 2003 | 38 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2004 | 302 | 0.060 |
Why?
|
Germany | 1 | 2022 | 72 | 0.060 |
Why?
|
RNA, Messenger | 2 | 2006 | 1981 | 0.050 |
Why?
|
beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase | 1 | 2002 | 2 | 0.050 |
Why?
|
Body Weight | 3 | 2016 | 459 | 0.050 |
Why?
|
Virus Replication | 2 | 2005 | 319 | 0.050 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2001 | 10 | 0.050 |
Why?
|
Hemin | 1 | 2001 | 5 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2022 | 55 | 0.050 |
Why?
|
Erythrocytes | 1 | 2003 | 255 | 0.050 |
Why?
|
Enzyme Activation | 3 | 2001 | 692 | 0.050 |
Why?
|
Transcription, Genetic | 2 | 2013 | 1135 | 0.050 |
Why?
|
Fas Ligand Protein | 2 | 1998 | 49 | 0.050 |
Why?
|
Gene Ontology | 1 | 2021 | 34 | 0.050 |
Why?
|
Palatine Tonsil | 1 | 2021 | 30 | 0.050 |
Why?
|
Genes, Immunoglobulin | 1 | 2001 | 111 | 0.050 |
Why?
|
Scrapie | 1 | 2001 | 2 | 0.050 |
Why?
|
Drug Combinations | 2 | 1998 | 224 | 0.050 |
Why?
|
Astrocytes | 1 | 2001 | 139 | 0.050 |
Why?
|
Clostridium botulinum | 1 | 2000 | 2 | 0.050 |
Why?
|
PrPSc Proteins | 1 | 2001 | 22 | 0.050 |
Why?
|
Janus Kinase 3 | 2 | 1998 | 9 | 0.050 |
Why?
|
Biolistics | 2 | 1998 | 3 | 0.050 |
Why?
|
Metabolism, Inborn Errors | 1 | 2000 | 30 | 0.050 |
Why?
|
Adolescent | 4 | 2022 | 8979 | 0.050 |
Why?
|
Financing, Organized | 1 | 2020 | 12 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2006 | 3636 | 0.050 |
Why?
|
Neuromuscular Diseases | 1 | 2000 | 30 | 0.050 |
Why?
|
Observational Studies as Topic | 1 | 2021 | 48 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2001 | 222 | 0.050 |
Why?
|
Internationality | 1 | 2020 | 69 | 0.050 |
Why?
|
Disease Susceptibility | 1 | 2001 | 193 | 0.050 |
Why?
|
Administration, Sublingual | 1 | 2020 | 5 | 0.050 |
Why?
|
Trisaccharides | 1 | 2000 | 12 | 0.050 |
Why?
|
Research Personnel | 1 | 2020 | 67 | 0.050 |
Why?
|
Bortezomib | 1 | 2020 | 76 | 0.050 |
Why?
|
Mice, Congenic | 1 | 2019 | 12 | 0.050 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 1999 | 19 | 0.050 |
Why?
|
Portasystemic Shunt, Surgical | 1 | 1999 | 12 | 0.050 |
Why?
|
Foscarnet | 1 | 1999 | 12 | 0.050 |
Why?
|
Lymphocyte Transfusion | 1 | 2019 | 41 | 0.050 |
Why?
|
Umbilical Veins | 1 | 1999 | 46 | 0.050 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 1999 | 25 | 0.050 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 134 | 0.050 |
Why?
|
3T3 Cells | 1 | 1999 | 94 | 0.050 |
Why?
|
B7-1 Antigen | 2 | 2013 | 75 | 0.040 |
Why?
|
Receptors, Growth Factor | 1 | 1999 | 52 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 1999 | 88 | 0.040 |
Why?
|
Staphylococcus epidermidis | 1 | 2019 | 14 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 1999 | 78 | 0.040 |
Why?
|
Pancreas | 1 | 2001 | 239 | 0.040 |
Why?
|
Artificial Intelligence | 1 | 2022 | 298 | 0.040 |
Why?
|
Neuropeptides | 1 | 1999 | 112 | 0.040 |
Why?
|
Models, Biological | 2 | 1998 | 1749 | 0.040 |
Why?
|
Drug Resistance, Multiple | 1 | 1999 | 20 | 0.040 |
Why?
|
Neoplasm Transplantation | 1 | 1999 | 391 | 0.040 |
Why?
|
Caspase 1 | 1 | 1998 | 18 | 0.040 |
Why?
|
Forkhead Transcription Factors | 1 | 2019 | 166 | 0.040 |
Why?
|
Leukemia, T-Cell | 1 | 1998 | 17 | 0.040 |
Why?
|
HT29 Cells | 1 | 1998 | 49 | 0.040 |
Why?
|
DNA Fragmentation | 1 | 1998 | 63 | 0.040 |
Why?
|
Platelet-Derived Growth Factor | 1 | 1998 | 67 | 0.040 |
Why?
|
Binding Sites | 2 | 2017 | 1098 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 1998 | 52 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2003 | 696 | 0.040 |
Why?
|
Stimulation, Chemical | 2 | 1996 | 63 | 0.040 |
Why?
|
Herpesvirus 1, Human | 1 | 2001 | 244 | 0.040 |
Why?
|
Vaccination | 1 | 2020 | 254 | 0.040 |
Why?
|
Cysteine Endopeptidases | 1 | 1998 | 87 | 0.040 |
Why?
|
Cytidine Triphosphate | 1 | 1997 | 3 | 0.040 |
Why?
|
Uridine Triphosphate | 1 | 1997 | 5 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 1998 | 119 | 0.040 |
Why?
|
Administration, Intranasal | 1 | 2018 | 136 | 0.040 |
Why?
|
Cell Survival | 2 | 2001 | 969 | 0.040 |
Why?
|
Mice, Inbred MRL lpr | 1 | 1997 | 36 | 0.040 |
Why?
|
Complement C3 | 1 | 1997 | 58 | 0.040 |
Why?
|
Immunotherapy, Active | 1 | 2017 | 15 | 0.040 |
Why?
|
Fibroblast Growth Factors | 1 | 1998 | 80 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2022 | 8475 | 0.040 |
Why?
|
Janus Kinase 1 | 1 | 1997 | 15 | 0.040 |
Why?
|
Nucleotide Motifs | 1 | 2017 | 47 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2021 | 355 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 1998 | 265 | 0.040 |
Why?
|
Betacoronavirus | 1 | 2020 | 258 | 0.040 |
Why?
|
Particle Size | 1 | 2017 | 122 | 0.040 |
Why?
|
Child | 2 | 2022 | 6926 | 0.040 |
Why?
|
Cell Membrane | 4 | 2000 | 666 | 0.040 |
Why?
|
Glioma | 1 | 1999 | 285 | 0.040 |
Why?
|
Research Design | 1 | 2021 | 594 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 1997 | 229 | 0.040 |
Why?
|
Comorbidity | 1 | 2021 | 943 | 0.040 |
Why?
|
Rifabutin | 1 | 1996 | 3 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 1996 | 10 | 0.040 |
Why?
|
Quinones | 1 | 1996 | 9 | 0.040 |
Why?
|
Lactams, Macrocyclic | 1 | 1996 | 14 | 0.040 |
Why?
|
Phosphotyrosine | 1 | 1996 | 32 | 0.040 |
Why?
|
Benzoquinones | 1 | 1996 | 27 | 0.040 |
Why?
|
Thymocytes | 1 | 2016 | 30 | 0.040 |
Why?
|
Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2016 | 17 | 0.040 |
Why?
|
Clindamycin | 1 | 2016 | 13 | 0.040 |
Why?
|
Survival Rate | 1 | 2021 | 1860 | 0.040 |
Why?
|
Drug Discovery | 1 | 2017 | 103 | 0.040 |
Why?
|
ErbB Receptors | 1 | 1999 | 485 | 0.040 |
Why?
|
Antigens, Ly | 1 | 1996 | 37 | 0.040 |
Why?
|
Leukemia | 2 | 2008 | 320 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2000 | 1565 | 0.040 |
Why?
|
PrPC Proteins | 1 | 1996 | 13 | 0.040 |
Why?
|
Diet, Fat-Restricted | 1 | 2016 | 30 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 2 | 2014 | 557 | 0.040 |
Why?
|
Rhodamine 123 | 2 | 1993 | 8 | 0.040 |
Why?
|
Verapamil | 2 | 1993 | 48 | 0.030 |
Why?
|
Rhodamines | 2 | 1993 | 18 | 0.030 |
Why?
|
Genistein | 1 | 1995 | 16 | 0.030 |
Why?
|
Neurotoxins | 1 | 1996 | 49 | 0.030 |
Why?
|
Isoflavones | 1 | 1995 | 13 | 0.030 |
Why?
|
Vanadates | 1 | 1995 | 29 | 0.030 |
Why?
|
Sulfhydryl Reagents | 1 | 1995 | 8 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 1313 | 0.030 |
Why?
|
Kupffer Cells | 1 | 1995 | 13 | 0.030 |
Why?
|
Prions | 1 | 1996 | 54 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 1996 | 165 | 0.030 |
Why?
|
Phospholipase C gamma | 1 | 1995 | 15 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fyn | 1 | 1995 | 24 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 1169 | 0.030 |
Why?
|
Leukocytes | 1 | 2016 | 202 | 0.030 |
Why?
|
Anopheles | 1 | 2014 | 4 | 0.030 |
Why?
|
Recurrence | 3 | 2008 | 1139 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2021 | 1801 | 0.030 |
Why?
|
Child, Preschool | 1 | 2022 | 3611 | 0.030 |
Why?
|
Antigens, Bacterial | 1 | 2015 | 134 | 0.030 |
Why?
|
Germ-Free Life | 1 | 2014 | 69 | 0.030 |
Why?
|
Macrophage-1 Antigen | 1 | 1994 | 17 | 0.030 |
Why?
|
Plasmodium falciparum | 1 | 2014 | 47 | 0.030 |
Why?
|
Amyloid beta-Peptides | 1 | 1996 | 203 | 0.030 |
Why?
|
Laser Capture Microdissection | 1 | 2014 | 20 | 0.030 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 2014 | 23 | 0.030 |
Why?
|
Empyema | 1 | 1994 | 9 | 0.030 |
Why?
|
Pandemics | 1 | 2020 | 740 | 0.030 |
Why?
|
Single-Chain Antibodies | 1 | 2014 | 17 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2014 | 134 | 0.030 |
Why?
|
Cell Separation | 2 | 1991 | 196 | 0.030 |
Why?
|
Alum Compounds | 1 | 2013 | 5 | 0.030 |
Why?
|
Protein Kinase C-theta | 1 | 2013 | 16 | 0.030 |
Why?
|
B7-2 Antigen | 1 | 2013 | 40 | 0.030 |
Why?
|
Nanotechnology | 1 | 2014 | 68 | 0.030 |
Why?
|
Ubiquitin | 1 | 2014 | 93 | 0.030 |
Why?
|
Proteomics | 1 | 2015 | 212 | 0.030 |
Why?
|
Positive Regulatory Domain I-Binding Factor 1 | 1 | 2013 | 13 | 0.030 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 1993 | 74 | 0.030 |
Why?
|
Fungal Proteins | 1 | 2014 | 141 | 0.030 |
Why?
|
Abdomen | 1 | 1994 | 122 | 0.030 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2013 | 14 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2013 | 43 | 0.030 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 78 | 0.030 |
Why?
|
Polyenes | 1 | 1993 | 8 | 0.030 |
Why?
|
Nitrophenols | 1 | 2013 | 11 | 0.030 |
Why?
|
Thymidine | 1 | 1993 | 59 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 1994 | 193 | 0.030 |
Why?
|
Tritium | 1 | 1993 | 133 | 0.030 |
Why?
|
Propylamines | 1 | 1993 | 9 | 0.030 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2013 | 41 | 0.030 |
Why?
|
Organophosphonates | 1 | 2013 | 50 | 0.030 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 1992 | 11 | 0.030 |
Why?
|
Rituximab | 1 | 2013 | 116 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2013 | 88 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 689 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2014 | 191 | 0.030 |
Why?
|
Autophagy | 1 | 2014 | 149 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1999 | 1075 | 0.030 |
Why?
|
Drug Interactions | 1 | 1993 | 248 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 1996 | 1014 | 0.030 |
Why?
|
Phagocytosis | 2 | 1995 | 85 | 0.030 |
Why?
|
Lymphocyte Subsets | 1 | 1991 | 64 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 1384 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2019 | 2207 | 0.030 |
Why?
|
Receptors, Concanavalin A | 1 | 1991 | 1 | 0.030 |
Why?
|
Oligopeptides | 1 | 2012 | 179 | 0.020 |
Why?
|
Gamma Rays | 1 | 1991 | 72 | 0.020 |
Why?
|
Alpha-Globulins | 1 | 1990 | 11 | 0.020 |
Why?
|
alpha 1-Antitrypsin | 1 | 1990 | 16 | 0.020 |
Why?
|
Lymphoma | 2 | 1990 | 262 | 0.020 |
Why?
|
Transforming Growth Factor alpha | 1 | 1990 | 50 | 0.020 |
Why?
|
Aged | 3 | 2014 | 18402 | 0.020 |
Why?
|
Tumor Stem Cell Assay | 1 | 1990 | 35 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 1990 | 40 | 0.020 |
Why?
|
Calcium | 1 | 1995 | 1156 | 0.020 |
Why?
|
Skin Diseases | 1 | 1992 | 166 | 0.020 |
Why?
|
Structure-Activity Relationship | 2 | 1995 | 408 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 1991 | 168 | 0.020 |
Why?
|
Tissue and Organ Procurement | 1 | 2014 | 311 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2012 | 736 | 0.020 |
Why?
|
Receptors, Fc | 1 | 1990 | 33 | 0.020 |
Why?
|
Neoplasms | 1 | 2005 | 2897 | 0.020 |
Why?
|
Killer Factors, Yeast | 1 | 1989 | 1 | 0.020 |
Why?
|
Cell-Free System | 1 | 1989 | 51 | 0.020 |
Why?
|
Phytohemagglutinins | 1 | 1989 | 22 | 0.020 |
Why?
|
Periodic Acid | 1 | 1988 | 4 | 0.020 |
Why?
|
Oligosaccharides | 1 | 1988 | 24 | 0.020 |
Why?
|
Neuraminidase | 1 | 1988 | 45 | 0.020 |
Why?
|
Trypsin | 1 | 1988 | 95 | 0.020 |
Why?
|
Biological Assay | 1 | 1989 | 78 | 0.020 |
Why?
|
Oligonucleotides | 1 | 2009 | 92 | 0.020 |
Why?
|
Clone Cells | 1 | 1989 | 213 | 0.020 |
Why?
|
Pluripotent Stem Cells | 1 | 2008 | 31 | 0.020 |
Why?
|
ROC Curve | 1 | 2010 | 752 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 247 | 0.020 |
Why?
|
Rats, Inbred F344 | 2 | 1998 | 156 | 0.020 |
Why?
|
Rodentia | 1 | 2007 | 42 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 879 | 0.020 |
Why?
|
Membrane Proteins | 2 | 1995 | 1196 | 0.020 |
Why?
|
Base Sequence | 2 | 2001 | 2330 | 0.020 |
Why?
|
Rosette Formation | 1 | 1986 | 34 | 0.020 |
Why?
|
Thioglycolates | 1 | 1986 | 2 | 0.020 |
Why?
|
Mycobacterium bovis | 1 | 1986 | 16 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2008 | 292 | 0.020 |
Why?
|
Transplantation, Isogeneic | 2 | 1997 | 39 | 0.020 |
Why?
|
Disease Progression | 1 | 2010 | 1531 | 0.020 |
Why?
|
Rose Bengal | 1 | 1985 | 3 | 0.020 |
Why?
|
Polyelectrolytes | 1 | 1985 | 6 | 0.020 |
Why?
|
Colorimetry | 1 | 1985 | 8 | 0.020 |
Why?
|
Endocytosis | 1 | 1986 | 177 | 0.020 |
Why?
|
Guinea Pigs | 1 | 1985 | 171 | 0.020 |
Why?
|
Carbohydrates | 1 | 1985 | 47 | 0.020 |
Why?
|
Alkynes | 1 | 2005 | 17 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2004 | 36 | 0.020 |
Why?
|
Alleles | 1 | 2008 | 1127 | 0.020 |
Why?
|
Neutrophils | 1 | 1986 | 307 | 0.020 |
Why?
|
Genetic Variation | 1 | 1991 | 1351 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2008 | 536 | 0.020 |
Why?
|
Membranes | 1 | 2004 | 36 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2008 | 669 | 0.020 |
Why?
|
Polymers | 1 | 1985 | 202 | 0.010 |
Why?
|
Temperature | 1 | 1985 | 396 | 0.010 |
Why?
|
Proteins | 1 | 1989 | 777 | 0.010 |
Why?
|
Nuclear Transfer Techniques | 1 | 2003 | 15 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 301 | 0.010 |
Why?
|
Immunoglobulin D | 1 | 2002 | 5 | 0.010 |
Why?
|
Leukosialin | 1 | 2002 | 16 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2003 | 207 | 0.010 |
Why?
|
Sialoglycoproteins | 1 | 2002 | 31 | 0.010 |
Why?
|
Phenanthrolines | 1 | 2001 | 7 | 0.010 |
Why?
|
Pregnatrienes | 1 | 2001 | 14 | 0.010 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2001 | 25 | 0.010 |
Why?
|
Butadienes | 1 | 2001 | 33 | 0.010 |
Why?
|
Cross Reactions | 1 | 2001 | 106 | 0.010 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2001 | 53 | 0.010 |
Why?
|
Free Radicals | 1 | 2001 | 73 | 0.010 |
Why?
|
Calcineurin Inhibitors | 1 | 2002 | 54 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 2001 | 72 | 0.010 |
Why?
|
Prednisone | 1 | 2002 | 258 | 0.010 |
Why?
|
Flavonoids | 1 | 2001 | 85 | 0.010 |
Why?
|
Blood Proteins | 1 | 2001 | 144 | 0.010 |
Why?
|
Endopeptidase K | 1 | 2001 | 12 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2002 | 253 | 0.010 |
Why?
|
Anemia | 1 | 2002 | 128 | 0.010 |
Why?
|
Vero Cells | 1 | 2001 | 100 | 0.010 |
Why?
|
Creatinine | 1 | 2002 | 338 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2001 | 290 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2004 | 579 | 0.010 |
Why?
|
Antioxidants | 1 | 2001 | 223 | 0.010 |
Why?
|
GA-Binding Protein Transcription Factor | 1 | 1999 | 1 | 0.010 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2000 | 14 | 0.010 |
Why?
|
Splanchnic Circulation | 1 | 1999 | 16 | 0.010 |
Why?
|
Jurkat Cells | 1 | 1999 | 77 | 0.010 |
Why?
|
Liver Circulation | 1 | 1999 | 30 | 0.010 |
Why?
|
Neurons | 2 | 2001 | 1546 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2010 | 6501 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2005 | 1937 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 1999 | 86 | 0.010 |
Why?
|
Thalamus | 1 | 2001 | 132 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 1999 | 125 | 0.010 |
Why?
|
Hot Temperature | 1 | 1999 | 206 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2001 | 480 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2001 | 447 | 0.010 |
Why?
|
STAT6 Transcription Factor | 1 | 1998 | 28 | 0.010 |
Why?
|
Cold Temperature | 1 | 1998 | 157 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1997 | 19 | 0.010 |
Why?
|
Enhancer Elements, Genetic | 1 | 1999 | 266 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 1997 | 71 | 0.010 |
Why?
|
Cell Nucleus | 1 | 1999 | 579 | 0.010 |
Why?
|
Hematoxylin | 1 | 1997 | 6 | 0.010 |
Why?
|
Eosine Yellowish-(YS) | 1 | 1997 | 10 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2001 | 584 | 0.010 |
Why?
|
Hippocampus | 1 | 2001 | 442 | 0.010 |
Why?
|
Nitric Oxide | 1 | 1998 | 278 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1996 | 68 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 1990 | 0.010 |
Why?
|
Circular Dichroism | 1 | 1996 | 117 | 0.010 |
Why?
|
PC12 Cells | 1 | 1996 | 115 | 0.010 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 1995 | 11 | 0.010 |
Why?
|
Ethers, Cyclic | 1 | 1995 | 7 | 0.010 |
Why?
|
Okadaic Acid | 1 | 1995 | 9 | 0.010 |
Why?
|
Marine Toxins | 1 | 1995 | 7 | 0.010 |
Why?
|
Dithiothreitol | 1 | 1995 | 26 | 0.010 |
Why?
|
Oxazoles | 1 | 1995 | 19 | 0.010 |
Why?
|
Cations, Divalent | 1 | 1995 | 39 | 0.010 |
Why?
|
Phosphoprotein Phosphatases | 1 | 1995 | 57 | 0.010 |
Why?
|
Naphthalenes | 1 | 1995 | 45 | 0.010 |
Why?
|
Bile | 1 | 1995 | 57 | 0.010 |
Why?
|
Transplantation Conditioning | 1 | 1997 | 373 | 0.010 |
Why?
|
Chronic Disease | 1 | 1998 | 970 | 0.010 |
Why?
|
Glycogen | 1 | 1995 | 59 | 0.010 |
Why?
|
HeLa Cells | 1 | 1996 | 498 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 1995 | 373 | 0.010 |
Why?
|
Duodenal Neoplasms | 1 | 1994 | 19 | 0.010 |
Why?
|
Ileostomy | 1 | 1994 | 30 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 1995 | 354 | 0.010 |
Why?
|
Cytoskeleton | 1 | 1995 | 193 | 0.010 |
Why?
|
Leiomyosarcoma | 1 | 1994 | 40 | 0.010 |
Why?
|
Cell Cycle | 1 | 1996 | 502 | 0.010 |
Why?
|
Weight Gain | 1 | 1994 | 123 | 0.010 |
Why?
|
Chloroquine | 1 | 1993 | 12 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 1995 | 371 | 0.010 |
Why?
|
Stearic Acids | 1 | 1993 | 11 | 0.010 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 1993 | 54 | 0.010 |
Why?
|
Perforin | 1 | 1993 | 55 | 0.010 |
Why?
|
Regression Analysis | 1 | 1994 | 596 | 0.010 |
Why?
|
Protein Conformation | 1 | 1995 | 881 | 0.010 |
Why?
|
CD4-CD8 Ratio | 1 | 1992 | 18 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 1994 | 552 | 0.010 |
Why?
|
Actins | 1 | 1995 | 451 | 0.010 |
Why?
|
Neuroblastoma | 1 | 1996 | 374 | 0.010 |
Why?
|
Probability | 1 | 1993 | 355 | 0.010 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1991 | 19 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1992 | 220 | 0.010 |
Why?
|
Biological Transport | 1 | 1991 | 396 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1993 | 912 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1993 | 927 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 1993 | 363 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1990 | 44 | 0.010 |
Why?
|
RNA | 1 | 1993 | 560 | 0.010 |
Why?
|
Interferons | 1 | 1989 | 133 | 0.010 |
Why?
|
DNA | 1 | 1993 | 1294 | 0.000 |
Why?
|